Milestone Scientific Inc. Stock Other OTC
Stocks
US59935P2092
Advanced Medical Equipment & Technology
|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 08-14 | Milestone Scientific Inc., Q2 2026 Earnings Call, Aug 14, 2026 | |
| 08-14 | Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 | CI |
| Market Cap | 38.52M 33.13M 31.26M 28.48M 53.23M 3.68B 53.71M 372M 143M 1.87B 145M 141M 5.93B | P/E 2026 * |
-10.9x | P/E 2027 * | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 38.52M 33.13M 31.26M 28.48M 53.23M 3.68B 53.71M 372M 143M 1.87B 145M 141M 5.93B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 3.39x |
| Free-Float |
83.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Milestone Scientific Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Hines
CEO | Chief Executive Officer | 58 | 2025-07-30 |
Keisha Harcum
DFI | Director of Finance/CFO | - | - |
Mark Hochman
CTO | Chief Tech/Sci/R&D Officer | 65 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Goldman
CHM | Chairman | 82 | 2023-01-03 |
| Chairman | 56 | 2024-12-31 | |
Didier Demesmin
BRD | Director/Board Member | 57 | 2023-09-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.41% | -2.47% | +26.57% | +16.38% | 224B | |
| -2.11% | -4.98% | +4.12% | -19.26% | 144B | |
| +2.04% | -2.53% | -19.89% | +20.87% | 125B | |
| -4.14% | -8.20% | -59.04% | -19.99% | 65.16B | |
| -0.70% | -1.00% | -20.42% | -13.99% | 50.05B | |
| +0.68% | -3.35% | +10.85% | +17.15% | 49.67B | |
| -1.13% | -4.57% | +15.31% | +25.55% | 40.81B | |
| -0.78% | -2.88% | +37.06% | +52.38% | 39.77B | |
| -0.17% | -4.19% | -18.82% | +48.42% | 31.47B | |
| Average | -0.58% | -3.71% | -2.70% | +14.17% | 85.52B | |
| Weighted average by Cap. | -0.64% | -3.35% | +1.61% | +9.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.97M 8.58M 8.09M 7.37M 13.78M 954M 13.91M 96.39M 37.1M 484M 37.45M 36.64M 1.54B | 11.35M 9.76M 9.21M 8.39M 15.68M 1.09B 15.83M 110M 42.22M 550M 42.62M 41.69M 1.75B |
| Net income | -3.76M -3.23M -3.05M -2.78M -5.2M -359M -5.24M -36.34M -13.98M -182M -14.12M -13.81M -579M | -3.36M -2.89M -2.72M -2.48M -4.64M -321M -4.68M -32.44M -12.48M -163M -12.6M -12.33M -517M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
